3rd annual AstraZeneca Multiplex Immunofluorescence in Immune Oncology Symposium and Workshop

Published on :

This four day program is divided into a two-day symposium with lectures presented by world class scientists in the field of immuno-oncology and with representation by all the main multiplex [….]

Cerecor Rebrands to Avalo Therapeutics

Published on :

Cerecor Rebrands to Avalo Therapeutics. Eighteen months after completing its merger with Aevi Genomic Medicine, Cerecor is rebranding to Avalo Therapeutics. The rebranding to Avalo reflects the company’s aims to focus on three core indications, on immunology, immuno-oncology, and rare genetic diseases.

Virtual DC Startup Showcase @ GW

Published on :

The George Washington University (GW) Technology Commercialization Office is pleased to host the inaugural DC Startup Showcase.DC Startup Showcase will present companies developing disruptive healthcare innovations. Log on to our [….]

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers

Published on :

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers VerImmune’s Novel technology platform enables redirection of pre-existing natural immunity towards fighting cancer [….]